The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

• Status: Completed
• Trial end date: 2012-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the investigators study is to evaluate whether alpha-blockers such as terazosin and anti-cholinergics such as tolterodine can be relieve the DJ-stent related symptoms.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Urmia University of Medical Sciences
• Treatments: Prazosin; Terazosin; Tolterodine Tartrate

Criteria

Inclusion Criteria:

If a patient does not meet any exclusion criteria and to be undergone double-J stent indwelling.

Exclusion Criteria:

1. Prior history of pelvic surgery

2. Prior history of Transurethral Resection of the either Prostate or Bladder Tumor

3. Benign prostate hyperplasia

4. Recent or recurrent urinary tract infection

5. Chronic medication with beta-blockers or Anti-cholinergic

6. Pregnancy

7. Prostatitis

8. Prostate cancer

9. Bilateral ureteroscopy or ureteral stenting

10. Age < 18 and > 55

11. Stone size > 20 mm

12. Diabetes

13. Bladder Outlet Obstruction